Ogilvie syndrome epidemiology and demographics

	Ogilvie syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ogilvie syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ogilvie syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ogilvie syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ogilvie syndrome epidemiology and demographics
CDC on Ogilvie syndrome epidemiology and demographics
Ogilvie syndrome epidemiology and demographics in the news
Blogs on Ogilvie syndrome epidemiology and demographics
Directions to Hospitals Treating Ogilvie syndrome
Risk calculators and risk factors for Ogilvie syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The incidence of Ogilvie's syndrome is 100 per 100,000 individuals. Ogilvie's syndrome commonly affects patients more than 60years and it is more prevelant int he men more than women.

Epidemiology and demographics

Incidence

Worldwide, the incidence of Ogilvie's syndrome is 100 per 100,000 inidividuals.^[1]

Age

Ogilvie's syndrome commonly affects patients more than 60 years old.^[2]

Gender

Ogilvie's syndrome is more prevalent in the men more than women.^[2]

Race

There is no racial predilection for Ogilvie's syndrome.

References

↑ Ross SW, Oommen B, Wormer BA, Walters AL, Augenstein VA, Heniford BT; et al. (2016). "Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvie's Syndrome". Am Surg. 82 (2): 102–11. PMID 26874130.
↑ ^2.0 ^2.1 Vanek VW, Al-Salti M (1986). "Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases". Dis Colon Rectum. 29 (3): 203–10. PMID 3753674.

[pmid26874130-1] Ross SW, Oommen B, Wormer BA, Walters AL, Augenstein VA, Heniford BT; et al. (2016). "Acute Colonic Pseudo-obstruction: Defining the Epidemiology, Treatment, and Adverse Outcomes of Ogilvie's Syndrome". Am Surg. 82 (2): 102–11. PMID 26874130.

[pmid3753674-2] 2.0 ^2.1 Vanek VW, Al-Salti M (1986). "Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases". Dis Colon Rectum. 29 (3): 203–10. PMID 3753674.

[1]

[2]